Documentation of the Patient Characteristics Morbid Obesity and Bariatric Surgery in the Hospital Information System and the Influence on the Number of Medication-Related Problems.

Autor: Kingma JS; Department of Clinical Pharmacy, St. Antonius Hospital, Nieuwegein, The Netherlands., Brenkman IAM; Department of Clinical Pharmacy, St. Antonius Hospital, Nieuwegein, The Netherlands.; Department of Pharmaceutics, Faculty of Science, Utrecht University, Utrecht, The Netherlands., van den Broek MPH; Department of Clinical Pharmacy, St. Antonius Hospital, Nieuwegein, The Netherlands.; Department of Pharmaceutics, Faculty of Science, Utrecht University, Utrecht, The Netherlands., van den Bemt PMLA; Department of Clinical Pharmacy and Pharmacology, University Medical Center Groningen, Groningen, The Netherlands., Janssen K; Department of Clinical Pharmacy, St. Antonius Hospital, Nieuwegein, The Netherlands., Knibbe CAJ; Department of Clinical Pharmacy, St. Antonius Hospital, Nieuwegein, The Netherlands.; Division of Systems Pharmacology and Pharmacy, Leiden Academic Centre for Drug Research, Leiden University, Leiden, The Netherlands., Burgers DMT; Department of Clinical Pharmacy, St. Antonius Hospital, Nieuwegein, The Netherlands.

Publikováno v: The Annals of pharmacotherapy [Ann Pharmacother] 2024 Oct; Vol. 58 (10), pp. 1020-1026. Date of Electronic Publication: 2024 Jan 24.

The potential for deprescribing in a palliative oncology patient population: a cross-sectional study.

Autor: van Merendonk LN; Clinical Pharmacy, Sint Antonius Hospital, Nieuwegein, The Netherlands l.v.merendonk@nki.nl., Peters BJM; Clinical Pharmacy, Sint Antonius Hospital, Nieuwegein, The Netherlands., Möhlmann JE; Clinical Pharmacy, Sint Antonius Hospital, Nieuwegein, The Netherlands., Hunting CB; Department of Internal Medicine, Sint Antonius Hospital, Nieuwegein, The Netherlands., Kastelijn EA; Department of Pulmonary Diseases, Sint Antonius Hospital, Nieuwegein, The Netherlands., van den Broek MPH; Clinical Pharmacy, Sint Antonius Hospital, Nieuwegein, The Netherlands.

Publikováno v: European journal of hospital pharmacy : science and practice [Eur J Hosp Pharm] 2023 Dec 27; Vol. 31 (1), pp. 10-15. Date of Electronic Publication: 2023 Dec 27.

Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastases.

Autor: Lazaratos AM; Rosalind and Morris Goodman Cancer Institute, Montreal, Quebec, Canada; Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada., Maritan SM; Rosalind and Morris Goodman Cancer Institute, Montreal, Quebec, Canada; Faculty of Medicine, Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada., Quaiattini A; Schulich Library of Physical Sciences, Life Sciences, and Engineering, McGill University, Montreal, Quebec, Canada., Darlix A; Department of Medical Oncology, Institut régional du Cancer de Montpellier, University of Montpellier, Montpellier, France; Institut de Génomique Fonctionnelle, INSERM, CNRS, University of Montpellier, Montpellier, France., Ratosa I; Division of Radiotherapy, Institute of Oncology Ljubljana, Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia., Ferraro E; Breast Cancer Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NewYork, USA., Griguolo G; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy., Guarneri V; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy; Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy., Pellerino A; Division of Neuro-Oncology, Department of Neuroscience, University and City of Health and Science Hospital, Turin, Italy., Hofer S; Department of Neurology, University Hospital Zurich, Switzerland., Jacot W; Department of Medical Oncology, Institut régional du Cancer de Montpellier, University of Montpellier, Montpellier, France., Stemmler HJ; Medical Dept. III, Ludwig Maximilians University Munich, Munchen, Germany., van den Broek MPH; Clinical Pharmacy, Sint Antonius Hospital, Nieuwegein, the Netherlands., Dobnikar N; Division of Radiotherapy, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Panet F; Gerald Bronfman Department of Oncology, Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada., Lahijanian Z; Department of Diagnostic Radiology, McGill University, Montreal, Quebec, Canada., Morikawa A; Breast Cancer Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NewYork, USA., Seidman AD; Breast Cancer Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, NewYork, USA., Soffietti R; Division of Neuro-Oncology, Department of Neuroscience, University and City of Health and Science Hospital, Turin, Italy., Panasci L; Gerald Bronfman Department of Oncology, Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada., Petrecca K; Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada., Rose AAN; Gerald Bronfman Department of Oncology, Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada; Lady Davis Institute, Segal Cancer Centre, Jewish General Hospital, McGill University, Montreal, Quebec, Canada., Bouganim N; Gerald Bronfman Department of Oncology, Faculty of Medicine and Health Sciences, McGill University, Montreal, Quebec, Canada; McGill University Health Centre, McGill University, Montreal, Quebec, Canada., Dankner M; Rosalind and Morris Goodman Cancer Institute, Montreal, Quebec, Canada; Faculty of Medicine, Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada. Electronic address: matthew.dankner@mail.mcgill.ca.

Publikováno v: Breast (Edinburgh, Scotland) [Breast] 2023 Jun; Vol. 69, pp. 451-468. Date of Electronic Publication: 2023 May 01.

Increased frequency of CYP2C19 loss-of-function alleles in clopidogrel-treated patients with recurrent cerebral ischemia.

Autor: Minderhoud C; University Medical Center Utrecht, Utrecht, Netherlands.; St. Antonius Hospital, Nieuwegein, Netherlands., Otten LS; St. Antonius Hospital, Nieuwegein, Netherlands.; Radboud University Medical Center, Nijmegen, Netherlands., Hilkens PHE; St. Antonius Hospital, Nieuwegein, Netherlands., van den Broek MPH; St. Antonius Hospital, Nieuwegein, Netherlands., Harmsze AM; St. Antonius Hospital, Nieuwegein, Netherlands.

Publikováno v: British journal of clinical pharmacology [Br J Clin Pharmacol] 2022 Jul; Vol. 88 (7), pp. 3335-3340. Date of Electronic Publication: 2022 Feb 28.

QTc Prolongation Risk Evaluation in Female COVID-19 Patients Undergoing Chloroquine and Hydroxychloroquine With/Without Azithromycin Treatment.

Autor: Grewal S; Pharmacovigilance, ContraRx, NJ, United States Edison, NJ, United States., Jankelson L; NYU Langone Health, New York University School of Medicine, New York, NY, United States., van den Broek MPH; Department of Clinical Pharmacy, St. Antonius Hospital, Utrecht, Netherlands., Cour M; Hospices Civils de Lyon, Hôpital Edouard Herriot, Service de Médecine-Intensive Réanimation, Lyon, France., Bachmann G; Women's Health Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, United States., Kostis JB; Cardiovascular Institute, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ, United States., Misra K; Pharmacovigilance, ContraRx, NJ, United States Edison, NJ, United States.

Publikováno v: Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2020 Sep 02; Vol. 7, pp. 152. Date of Electronic Publication: 2020 Sep 02 (Print Publication: 2020).